Global Axial Spondyloarthritis (axSpA) Market Report 2023

Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The

Related Keywords

Russia ,Belgium ,United States ,Dublin ,Ireland ,Ukraine ,America ,Eli Lilly ,Arthritis Musculoskeletal Health ,Kyowa Kirin Co ,Regeneron Pharmaceuticals Inc ,Horizon Therapeutics Public Ltd Co ,Johnson Private ,European Commission ,Teva Pharmaceutical Industries Ltd ,Pozen Inc ,Abbvie Inc ,Bristol Myers Squibb Company ,Pfizer Inc ,Vertex Pharmaceuticals Incorporated ,Ipsen Technologies Pvt Ltd ,Iroko Pharmaceuticals ,Takeda Pharmaceutical Company ,Boehringer Ingelheim International Gmb ,Mitsubishi Tanabe Pharma Corporation ,Abbott Laboratories ,Gilead Sciences Inc ,Sun Pharmaceutical Industries Ltd ,European Union ,Celgene Corporation ,Biogen Inc ,Acelyrin Inc ,Astrazeneca ,Axial Spondyloarthritis ,Market Report ,Versus Arthritis ,Musculoskeletal Health Report ,United Kingdom Based ,New European Commission ,Research And Markets ,Xspa Market ,Inflammatory Drugs ,Heumatic Drug ,Tnf Alpha Inhibitors ,Tumor Necrosis Factor ,